Real-time enrollment status for this lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 10:40 PM UTC
| NCT Number | NCT04442022 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 501 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | May 6, 2026 (3 weeks ago) |
As of June 1, 2026: Clinical trial NCT04442022 is currently active_not_recruiting participants. This clinical trial study for lymphoma is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04442022 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04442022 was last updated 3 weeks ago (May 6, 2026). HelloStudys verifies this status automatically.